Rachman Ilya M 4
4 · Immix Biopharma, Inc. · Filed Nov 15, 2022
Insider Transaction Report
Form 4
Rachman Ilya M
DirectorCEO and Chairman
Transactions
- Purchase
Common Stock
2022-11-14$1.02/sh+4,050$4,127→ 906,550 total - Purchase
Common Stock
2022-11-14$0.95/sh+1,000$950→ 907,550 total - Purchase
Common Stock
2022-11-14$0.99/sh+150$149→ 907,700 total